Thank you for joining the E-Science Webinar 04
The next webinar will be on the 9th of July 2021, Keynote speaker : Prof Filippo Crea, Italy
in collaboration with
Upcoming Webinar
Recent data about coronary revascularization and medical therapy: implications in clinical practice
9 July 2021 – 14.00-15:30 CEST (Paris time)
Kaski Juan-Carlos - PICTURE
user
Juan Carlos Kaski
UK
( Chair )
Filippo
user
Filippo Crea,
Italy
Reappraisal of optimal medical therapy vs PCI in chronic coronary syndromes
Mutlu
user
Bülent Mutlu,
Turkey
Clinical case discussion
Abdelhamid.Magdy
user
Magdy Abdelhamid
(Egypt)
Panel discussion with speakers and international discussants
circle-cropped31.png
user
Luis Henrique Gowdak
(Brazil)
Panel discussion with speakers and international discussants
in collaboration with
Past webinar
E-Science Webinar 02
Management of post-PCI Angina
12th March 2021
E-Science Webinar 03
Personalized Management of angina
20th April 2021
E-Science Webinar 04
Angina management in clinical practice: from prevention to symptoms control
27th of May -2021
Thank you for joining the E-Science Webinar 04
The next webinar will be on the 9th of July 2021, Keynote speaker : Prof Filippo Crea, Italy
in collaboration with
Upcoming Webinar
Recent data about coronary revascularization and medical therapy: implications in clinical practice
9 July 2021 – 14.00-15:30 CEST (Paris time)
Kaski Juan-Carlos - PICTURE
user
Juan Carlos Kaski
UK
( Chair )
Filippo
user
Filippo Crea,
Italy
Reappraisal of optimal medical therapy vs PCI in chronic coronary syndromes
Mutlu
user
Bülent Mutlu,
Turkey
Clinical case discussion
Abdelhamid.Magdy
circle-cropped32.png
profile-white1.png
Magdy Abdelhamid
(Egypt)
Luis Henrique Gowdak (Brazil)
Panel discussion with speakers and international discussants
in collaboration with
Past webinar
E-Science Webinar 02
Management of post-PCI Angina
12th March 2021
E-Science Webinar 03
Personalized Management of angina
20th April 2021
E-Science Webinar 04
Angina management in clinical practice: from prevention to symptoms control
27th of May -2021
E-Science webinar 2
Management of post-PCI Angina
12 March 2021
circle-cropped2 op
user
Giuseppe Rosano UK
Abdelhamid.Magdy
user
Magdy Abdelhamid Egypt
circle-cropped3 op
user
Luis Henrique W. Gowdak Brazil
user
Interactive Discussion

new-cover-bg
Upcoming Webinar

Recent data about coronary revascularization and
medical therapy: implications in clinical practice
9 July 2021 - 14.00-15:30 CEST (Paris time)

Filippo Crea, Italy
Reappraisal of optimal
medical therapy vs PCI
in chronic coronary
syndromes
line2
Juan Carlos Kaski
UK
( Chair )
Bülent Mutlu, Turkey
Clinical case discussion
Magdy Abdelhamid (Egypt)
Panel discussion with speakers
and international discussants
line2
Luis Henrique Gowdak (Brazil)
new-cover-bg
Past Webinar

E-Science Webinar 02
Management of post- PCI Angina
of angina
12th March 2021

line2 View webinar
E-Science Webinar 03

Personalized Management
of angina
20th April 2021
View webinar
E-Science Webinar 04

Angina management in clinical practice:
from prevention to symptoms control
27th of May -2021
View webinar line2
calanderApril 2021

Video of the week


Editor-image

ANGINA IN INDIA

Chronic stable angina has various clinical presentations, In the context of the Angina Awareness project, Prof Viveka Kumar, India explains how he manages his patients with Angina. He explains the benefits his patients derive from appropriate medical management.

calanderBy G. Bozet, MDcalander31 May 2021

IN THE LITERATURE THIS WEEK


Featured image

From pathophysiology to evidence-based treatment of IHD

In this review, C. Berry et al. (British Heart Foundation, Glasgow, UK) consider the definitions of angina and myocardial ischaemia. They clarify pathophysiology, focusing on the mechanistic links between myocardial ischaemia and anginal symptoms, the difference between coronary heart disease and IHD, and the relative merits of non-invasive diagnostic tests and related clinical management.

calanderBy Dr. Williamcalander23 December 2020

Medical Education


Angina ccs guidlines

There have been no landmark trials necessitating a major change regarding the drugs recommended for angina treatment since the 2013 guidelines. Newer second-line drugs such as nicorandil, ranolazine, ivabradine and trimetazidine, have class IIa recommendations when symptoms are not adequately controlled by first-line drugs and nitrates.

calanderBy Dr. Jadecalander23 December 2020

Angina In the world


Angina in brazil

Antithrombotic therapy: In earlier guidelines, aspirin was recommended in all patients with coronary artery disease. In the 2019 guideline, it is stated that “Aspirin 75‐100 mg daily is recommended in patients with a previous MI or revascularization and “Aspirin 75‐100 mg daily may be considered in patients without a history of MI or revascularization, but with definitive evidence of CAD on imaging.

Featured image
calanderBy admincalander27 April 2021
Chest pain after revascularisation

Some patients can have persistent post-PCI angina. Prof Vinereanu, Romania, explains how to manage this situation with additional diagnostic testing and adaptation of optimal tolerated medical therapy. The ESC guidelines are the gold standard that most healthcare professionals follow in Romania

Featured image
calanderBy admincalander9 April 2021
Angina pectoris: what should patients know

Anginal pain is the alarm system of the heart. Prof Vinereanu, Romania provides a reminder about angina pectoris and what all patients should know. He focuses on the patients journey, and the important role of lifestyle interventions

Featured image
calanderBy D. Beardcalander29 March 2021
Case discussion- physically active man with stable CAD

In a clinical commentary, WE Boden and GBJ Mancini, call to mind a clinical scenario of a physically active man with stable CAD. The patient was largely asymptomatic with only occasional symptoms of presumed angina at a high workload. He was faced with making a difficult choice of proceeding with either urgent coronary artery bypass graft surgery within 24 hours or his usual approach of self-informing before making important decisions.

RSS Follow latest articles on microvascular angina
Featured image
calanderBy admincalander11 June 2021
CONGRESS COVERAGE

E. Navarese et al. (Nicolaus Copernicus University, Poland) presented the results of a new meta-analysis of revascularisation plus medical therapy versus medical therapy alone in patients with chronic coronary syndromes. A total of 19,806 patients with chronic coronary syndromes undergoing elective revascularisation from 25 randomised trials were pooled.

Featured image
calanderBy D. Beardcalander11 June 2021
Management of stable ischaemic heart disease: an overview

This article by Q. Radaideh et a. (Midwest Cardiovascular Research Foundation, USA) reviews the evidence on optimal medical therapy versus coronary revascularization in patients with stable ischaemic heart disease. The recently published ISCHEMIA trial has established the non-inferiority of medical therapy in comparison to coronary revascularisation in patients with moderate to severe ischaemia.

Featured image
calanderBy D. Beardcalander31 May 2021
Cardiac rehabilitation: frailty and coronary syndromes

Frailty and CVD in the elderly share pathophysiological mechanisms and associated conditions, such as malnutrition, sarcopenia, anaemia, polypharmacy and both increased bleeding/thrombotic risk.
In geriatric populations, acute coronary syndromes are associated with an increased frailty degree. Frail elderly patients are increasingly referred to cardiac rehabilitation programs after acute coronary syndromes.

Featured image
calanderBy D. Beardcalander17 May 2021
Cardioprotection in perspective

Despite the increasing use, better logistics and improved methodology of interventional approaches for coronary reperfusion, the mortality and morbidity from acute myocardial infarction are still substantial. This is very clear when examining the real world data. This issue is complex: patients with acute myocardial infarction are typically advanced in age, have comorbidities and are receiving several medications. For them, it is necessary to consider not only infarct size reduction but also attenuation of coronary microvascular obstruction, as well as longer-term targets including infarct repair and reverse remodelling.

Featured image
calanderBy G. Bozet, MDcalander23 March 2021
Health status after conservative care in CAD and advanced kidney disease

In the ISCHEMIA trial, an invasive strategy with angiographic assessment and revascularization did not reduce clinical events among patients with stable ischemic heart disease and moderate or severe ischemia. A secondary objective of the trial was to assess angina-related health status among these patients.

Featured image
calanderBy admincalander16 March 2021
Genetic dysregulation of ET-1 and microvascular dysfunction

T. J. Ford et al. (British Heart Foundation, UK) performed a multimodality investigation into the role of ET-1 and this gene variant in the pathogenesis of coronary microvascular dysfunction in 391 patients with symptoms and/or signs of ischaemia but no obstructive coronary artery disease.

Featured image
calanderBy G. Bozet, MDcalander16 March 2021
Coronary microvascular dysfunction in stable IHD

This review by U. Sechtem et al. (Robert Bosch Krankenhaus, Stuttgart, Germany) focuses on the challenges of identifying the presence of CMD in the context of diffuse non-obstructive CAD and obstructive CAD.

Featured image
calanderBy G. Bozet, MDcalander2 March 2021
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’

A significant percentage of patients suffer ischaemic events in the absence of epicardial coronary artery obstruction. Coronary microvascular dysfunction (CMD) refers to a term covering a wide spectrum of clinical situations in which the structure and function of the coronary microcirculation is affected

Featured image
calanderBy Prof. M Abdelhamidcalander22 February 2021
Management of Angina in Egypt

Prof Magdy Abdelhamid, Cairo, Egypt, explains why the Angina Updates initiative is so relevant for clinicians and patients in Egypt. Angina and Coronary Artery Disease are very prevalent in connection with the obesity pandemic, and the discussion around risks assessments and symptoms management is critical.

Featured image
calanderBy Prof. G Rosanocalander16 February 2021
Coming soon: the role of vascular ultrasound in patients with coronary artery disease

Prof Rosano will lead an educational project to improve knowledge and skills in the field of vascular ultrasound. Create an account on Angina Updates to receive more information.

Podcasts


Joints are the areas where two or more bones meet. Most joints are mobile, allowing the bones to move. Joints consist of the following: Cartilage – at the joint, the bones are covered with cartilage (a connective tissue), which is made up of cells and fibers and is wear-resistant. Cartilage helps reduce the friction of movement. Synovial membrane months, and years to a lifetime....
Featured image
calanderBy Dr. Williamcalander23 December 2020
Brazilian Society of Cardiology

biomarkers in angina

Emphasis is placed on the various lifestyle modifications as outlined in the recent lipids and preventive guidelines

Featured image
calanderBy Dr. Zephcalander23 December 2020
AHA 2021

What’s new in 2021

Despite significant advances in medical technology and pharmacology, cardiovascular disease remains a leading

Video


Video
author By Prof. G Rosano calander 24 June 2021
Cardiovascular disease remains the number one cause of death and disability around the globe.
Featured image
calanderBy admincalander27 April 2021
Chest pain after revascularisation

Some patients can have persistent post-PCI angina. Prof Vinereanu, Romania, explains how to manage this situation with additional diagnostic testing and adaptation of optimal tolerated medical therapy. The ESC guidelines are the gold standard that most healthcare professionals follow in Romania

Featured image
calanderBy admincalander9 April 2021
Angina pectoris: what should patients know

Anginal pain is the alarm system of the heart. Prof Vinereanu, Romania provides a reminder about angina pectoris and what all patients should know. He focuses on the patients journey, and the important role of lifestyle interventions